معرفی
Carlo Pulitano serves as Associate Professor of Transplantation Surgery (Translational Science) at the University of Sydney's Central Clinical School and works as a consultant at Royal Prince Alfred Hospital. He directs the RPA Translational Center for Organ Assessment, Repair and Optimization and the Center for Advanced Research in Liver Pancreas Biliary Surgery. His clinical and research work bridges transplantation surgery, hepatobiliary oncology, and innovative organ preservation technologies.
Dr. Pulitano's research interests focus on developing revolutionary technologies for organ repair and modification for transplantation, particularly perfusion systems that can extend organ survival up to 7 days. His other major research area is Liver Transplant Oncology, where he develops new protocols for managing patients with unresectable cholangiocarcinoma and colorectal metastases. His current projects include long-term ex-vivo organ preservation, clinical trials in cholangiocarcinoma and colorectal metastases, ex-vivo liver transplant techniques, bile duct injury research, and near-infrared imaging applications in surgery.
Analysis of his recent publications shows a strong focus on intrahepatic cholangiocarcinoma, with numerous studies examining surgical techniques, predictive models, recurrence patterns, and innovative approaches to liver cancer management. His work frequently combines clinical research with technological innovation, particularly in machine learning applications for surgical outcomes prediction and advanced organ preservation techniques.
- 2023 Rising Star Award, International Liver Transplantation Society (Mentor)
- 2023 Mentee-Mentor Award, The Transplantation Society (TTS)
- 2022 John Mitchel Crouch Fellowship (RACS)
- 2015 Rising Star Award, International Liver Transplantation Society (Investigator)
- 2014 Sir Roy McCaughey Research Fellowship, Royal Australian College of Surgeons
Dr. Pulitano actively supervises undergraduate and graduate students and collaborates with numerous international research teams. His leadership in the RPA Translational Center has positioned him at the forefront of innovative approaches to organ assessment, repair, and optimization. His work on extending organ viability through advanced perfusion systems represents a significant advancement in transplantation medicine that could dramatically increase the availability of transplantable organs.
